Xlife Sciences (Switzerland) Performance

XLS Stock   22.50  0.20  0.88%   
On a scale of 0 to 100, Xlife Sciences holds a performance score of 6. The firm maintains a market beta of 0.97, which attests to possible diversification benefits within a given portfolio. Xlife Sciences returns are very sensitive to returns on the market. As the market goes up or down, Xlife Sciences is expected to follow. Please check Xlife Sciences' sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to make a quick decision on whether Xlife Sciences' historical returns will revert.

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Xlife Sciences AG are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Xlife Sciences showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1
Xlife Sciences AG Provides Update on VERAXA Biotech AGs NASDAQ Listing Process Following U.S. Government Shutdown - MarketScreener
11/28/2025
2
What analysts say about Xlife Sciences AG XLS stock - Economic Data Impact Low Cost Capital Growth - earlytimes.in
12/02/2025
3
Award-Winning Liver PET Tracer Highlights the Strength of Our Innovation Portfolio - TradingView
12/11/2025
4
Can Xlife Sciences AG stock sustain margin levels - 2025 Market Overview Growth Focused Entry Point Reports -
12/18/2025
5
Xlife Sciences advances Landsteiner partnership and VERAXA milestones ahead of pivotal 2026 - MSN
01/20/2026
Begin Period Cash Flow218.7 K
Total Cashflows From Investing Activities-4 M
Free Cash Flow-433.6 K
  

Xlife Sciences Relative Risk vs. Return Landscape

If you would invest  1,900  in Xlife Sciences AG on November 30, 2025 and sell it today you would earn a total of  350.00  from holding Xlife Sciences AG or generate 18.42% return on investment over 90 days. Xlife Sciences AG is generating 0.3778% of daily returns assuming 4.4082% volatility of returns over the 90 days investment horizon. Simply put, 39% of all stocks have less volatile historical return distribution than Xlife Sciences, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Xlife Sciences is expected to generate 5.81 times more return on investment than the market. However, the company is 5.81 times more volatile than its market benchmark. It trades about 0.09 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of risk.

Xlife Sciences Target Price Odds to finish over Current Price

The tendency of Xlife Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 22.50 90 days 22.50 
about 46.42
Based on a normal probability distribution, the odds of Xlife Sciences to move above the current price in 90 days from now is about 46.42 (This Xlife Sciences AG probability density function shows the probability of Xlife Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Xlife Sciences has a beta of 0.97. This entails Xlife Sciences AG market returns are correlated to returns on the market. As the market goes up or down, Xlife Sciences is expected to follow. Additionally Xlife Sciences AG has an alpha of 0.4758, implying that it can generate a 0.48 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Xlife Sciences Price Density   
       Price  

Predictive Modules for Xlife Sciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Xlife Sciences AG. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
18.2422.6527.06
Details
Intrinsic
Valuation
LowRealHigh
17.7022.1126.52
Details
Naive
Forecast
LowNextHigh
19.7124.1228.53
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.14-0.14-0.14
Details

Xlife Sciences Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Xlife Sciences is not an exception. The market had few large corrections towards the Xlife Sciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Xlife Sciences AG, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Xlife Sciences within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.48
β
Beta against Dow Jones0.97
σ
Overall volatility
2.45
Ir
Information ratio 0.11

Xlife Sciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Xlife Sciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Xlife Sciences AG can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Xlife Sciences AG had very high historical volatility over the last 90 days
Xlife Sciences AG has accumulated about 99.03 K in cash with (421.51 K) of positive cash flow from operations.
Roughly 27.0% of the company outstanding shares are owned by insiders

Xlife Sciences Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Xlife Stock often depends not only on the future outlook of the current and potential Xlife Sciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Xlife Sciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding5.7 M
Cash And Short Term Investments99 K

Xlife Sciences Fundamentals Growth

Xlife Stock prices reflect investors' perceptions of the future prospects and financial health of Xlife Sciences, and Xlife Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Xlife Stock performance.

About Xlife Sciences Performance

Evaluating Xlife Sciences' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Xlife Sciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Xlife Sciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Xlife Sciences is entity of Switzerland. It is traded as Stock on SW exchange.

Things to note about Xlife Sciences AG performance evaluation

Checking the ongoing alerts about Xlife Sciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Xlife Sciences AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Xlife Sciences AG had very high historical volatility over the last 90 days
Xlife Sciences AG has accumulated about 99.03 K in cash with (421.51 K) of positive cash flow from operations.
Roughly 27.0% of the company outstanding shares are owned by insiders
Evaluating Xlife Sciences' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Xlife Sciences' stock performance include:
  • Analyzing Xlife Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Xlife Sciences' stock is overvalued or undervalued compared to its peers.
  • Examining Xlife Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Xlife Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Xlife Sciences' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Xlife Sciences' stock. These opinions can provide insight into Xlife Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Xlife Sciences' stock performance is not an exact science, and many factors can impact Xlife Sciences' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Xlife Stock Analysis

When running Xlife Sciences' price analysis, check to measure Xlife Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xlife Sciences is operating at the current time. Most of Xlife Sciences' value examination focuses on studying past and present price action to predict the probability of Xlife Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xlife Sciences' price. Additionally, you may evaluate how the addition of Xlife Sciences to your portfolios can decrease your overall portfolio volatility.